Effect of mometasone furoate nasal spray, loratadine and health education on children with allergic rhinitis and its effect on IL-10 and IL-17
10.3969/j.issn.1005-1678.2017.08.090
- VernacularTitle:糠酸莫米松鼻喷剂、氯雷他定、健康教育联合治疗小儿变应性鼻炎的临床疗效及对IL-10,IL-17的影响
- Author:
Kangkang MENG
;
Chao YING
- Keywords:
acid Momison;
loratadine;
health education;
allergic rhinitis;
interleukin -10;
interleukin -17
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(8):218-219,221
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical curative effect of combined treatment of mometasone furoate nasal spray, loratadine, health education on children with allergic rhinitis and effects on IL-10 and IL-17. Methods 50 children with allergic rhinitis in our hospital from January 2015 to December 2016 were selected,and according to the different treatment methods divided into observation group and control group,25 cases in each groups.The control group were treated with loratadine, observation group with mometasone furoate nasal spray of loratadine + + health education treatment; we observed the two groups before and after treatment in children with nasal symptoms score, IL-10 and IL-17 and the incidence of adverse reactions, and the relevant data for comparative analysis. Results Mometasone furoate nasal spray of loratadine + + Health Education (observation group) the effect of treatment of children with allergic nasal is better than loratadine (control group) treatment, symptoms to improve the situation, IL-10 and IL-17 are better than the control group, the difference was statistically significant (P<0.05); two groups children with adverse reaction rate comparison, the difference was not statistically significant. Conclusion Children with allergic rhinitis selection of mometasone furoate nasal spray + loratadine + health education treatment effect significantly, can effectively improve the symptoms, IL-10 and IL-17, and will not increase the incidence of adverse reactions, it is worthy of clinical application.
